Debut Plus

545.3

-33.14 -5.73%

17 Jul 2026

NSE Listed

Metropolis Healthcare Limited (METROPOLIS)

Volume: 1,51,118Avg Vol 1W: 2,49,065.8Avg Vol 1M: 3,16,120.552W Range:412.25600
Market Cap₹11,051 Cr
Current Price₹545.3
Previous Close₹578.44
High / Low (52w)₹600 / ₹412.25
Volume1,51,118
Avg Vol (1W)2,49,065.8
Avg Vol (1M)3,16,120.5
Stock P/E58.06
Book Value₹73.13
Dividend Yield0.4%
ROE13.4%
ROA8.3%
Revenue (TTM)₹1,646 Cr
Revenue Growth
Profit Margin
Total Debt₹232 Cr
Shares Outstanding21 Cr
Face Value₹2
EPS (TTM)₹9.18
P/B7.29
Debt / Equity15.21
50 DMA₹542.56
200 DMA₹494.87
Day change-5.73%
Price Chart
545.3 11.18% · 1Y
57442293.4L
2025-07-17
2026-07-16

20-day avg volume: 3.2L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 14% YoY.
  • Stock trades at a high P/E of 58.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1,646 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹190 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2,138 Cr
Total Liabilities₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹613 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1,513 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹232 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹351 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-223 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-115 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹300 Cr
Shareholding
Promoter 48.86% Institutions 44.99% Public 6.15%
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search